Agonist actions of dihydroergotamine at 5-HT(2B) and 5-HT(2C) receptors and their possible relevance to antimigraine efficacy

1. The pharmaceutical compound, dihydroergotamine (DHE) is dispensed to prevent and reduce the occurrence of migraine attacks. Although still controversial, the prophylactic effect of this drug is believed to be caused through blockade and/or activation of numerous receptors including serotonin (5-H...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Schaerlinger, B, Hickel, P, Etienne, N, Guesnier, L, Maroteaux, L
Médium: Artigo
Jazyk:Inglês
Vydáno: 2003
Témata:
Papers
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1574033/
https://ncbi.nlm.nih.gov/pubmed/12970106
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0705437
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky